CCL21 and hepatocellular carcinoma: Therefore, based on our findings, adjuvant CCL21 therapy disrupt the role of neutrophils in forming an immunosuppressive TME and enhance the therapeutic efficacy of immunotherapy in HCC, which has great clinical translational value.